Patients receiving treatment for carpal tunnel syndrome (CTS) prefer to play a more collaborative role when it comes to making decisions about their medical or surgical care, according to the findings of an August 3rd issue of the Journal of Bone and Joint Surgery (JBJS).
“While other studies have shown patients with potentially life-threatening conditions such as cancer tend to prefer a more passive role when it comes to decision-making, this study demonstrates that in carpal tunnel syndrome, which raises issues of quality of life rather than those related to a life-threatening condition, the majority of patients preferred to share decision making with their physicians,” said study author and orthopaedic surgeon Hyun Sik Gong, MD, PhD.Study Details and Findings
According to the study results, patients were more likely to assume an active role in the decision-making process if they:had undergone one or more previous surgical procedures;
Dr. Gong said that previous studies have described three primary approaches to medical decision-making:
And the shared decision-making, or collaborative, model, in which the physician and patient make the decision together and exchange medical and other information related to the patient’s health. Dr. Gong added that previous studies have shown that this type of decision making leads to greater patient satisfaction in medical or surgical treatment.
“This study shows the majority of patients wanted to share decision-making with their physicians, and patients should feel comfortable asking questions and expressing their preferences regarding care. Patient-centered care emphasizes the incorporation of individual styles of decision making to provide a more patient-centered consultation,” Dr. Gong added.
In a ‘patient-centered’ approach, patients’ cultural traditions, personal preferences and values, family situations, social circumstances and lifestyles are considered in the decision-making process.
Patient-centered care presumes active involvement of patients and their families in health care and in decision-making about individual options for treatment, and is identified as one of important factors constituting high-quality health care, Dr. Gong continued.
Although the current study did not determine which type of role, if any, resulted in better surgical outcomes, Dr. Gong said a subsequent study is being conducted evaluating surgical outcomes and patients’ preferred levels of involvement.
“Symptoms and signs of CTS are widely recognized, but the natural history is still unclear,” Dr. Gong said. “There are several treatment options available for CTS, but a discussion between a patient and his or her physician, based upon what activities patients need to pursue will help them achieve their mutual goal of getting back to activities, together. Therefore, the need for patient involvement in CTS is different from the treatment for other orthopaedic conditions such as fractures or bone tumors, where the decision can be more straightforward or depend on the physician’s decision.”
Patients considering treatment of carpal tunnel syndrome or any orthopaedic injury should feel comfortable with their provider’s level of involvement and not be afraid to ask questions or speak up, Dr. Gong noted.
Disclosure: None of the authors received payments or services, either directly or indirectly (i.e., via his or her institution), from a third party in support of any aspect of this work. None of the authors, or their institution(s), have had any financial relationship, in the thirty-six months prior to submission of this work, with any entity in the biomedical arena that could be perceived to influence or have the potential to influence what is written in this work. Also, no author has had any other relationships, or has engaged in any other activities, that could be perceived to influence or have the potential to influence what is written in this work.
More information on carpal tunnel symptoms and treatment can be found at www.orthoinfo.org
Lauren Pearson | EurekAlert!
The end of pneumonia? New vaccine offers hope
23.10.2017 | University at Buffalo
Scientists track ovarian cancers to site of origin: Fallopian tubes
23.10.2017 | Johns Hopkins Medicine
Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...
University of Maryland researchers contribute to historic detection of gravitational waves and light created by event
On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...
Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.
Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....
Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).
When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...
Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.
How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...
23.10.2017 | Event News
17.10.2017 | Event News
10.10.2017 | Event News
23.10.2017 | Life Sciences
23.10.2017 | Physics and Astronomy
23.10.2017 | Health and Medicine